Dorian A Rosen, PhD, (left) and Alban Gaultier, PhD, found last year that fluvoxamine may stop the deadly inflammation known as sepsis. The drug is now being tested as a protective measure for patients with COVID-19.
Media Contact
November 15, 2023
UVA Health Earns WebMD Patient Choice, Medscape Provider Choice Awards
November 14, 2023
$3.37 Million Grant Backs Effort to Optimize Online Weight Programs